Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00527800Phase 3Completed
A Phase 3 trial of dihydroartemisinin + piperaquine, trimethoprim + sulfamethoxazole in malaria, sponsored by University of California, San Francisco. Started Aug 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00527800.